@article {1821, title = {Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies.}, journal = {Lancet}, volume = {360}, year = {2002}, month = {2002 Jul 13}, pages = {119-29}, abstract = {Insufficient data are available from single cohort studies to allow estimation of the prognosis of HIV-1 infected, treatment-naive patients who start highly active antiretroviral therapy (HAART). The ART Cohort Collaboration, which includes 13 cohort studies from Europe and North America, was established to fill this knowledge gap.}, keywords = {Adolescent, Adult, Antiretroviral Therapy, Highly Active, CD4 Lymphocyte Count, Europe, Female, HIV Infections, HIV-1, Humans, Male, Middle Aged, Prognosis, Prospective Studies, Risk Factors, Survival Analysis, United States, Viral Load}, issn = {0140-6736}, doi = {10.1016/S0140-6736(02)09411-4}, author = {Egger, Matthias and May, Margaret and Ch{\^e}ne, Genevi{\`e}ve and Phillips, Andrew N and Ledergerber, Bruno and Dabis, Fran{\c c}ois and Costagliola, Dominique and d{\textquoteright}Arminio Monforte, Antonella and de Wolf, Frank and Reiss, Peter and Lundgren, Jens D and Justice, Amy C and Staszewski, Schlomo and Leport, Catherine and Hogg, Robert S and Sabin, Caroline A and Gill, M John and Salzberger, Bernd and Sterne, Jonathan A C} }